MC1R and metastatic melanoma: When comparing across benign nevi, primary, and metastatic melanomas, MC1R expression was significantly higher in primary melanomas than benign nevi (p < 0.0001) and higher in metastases than in primary sites (p < 0.0001), as shown in Figure 2A.